[go: up one dir, main page]

NO970910D0 - Spirostanylglykosidal-krystaller - Google Patents

Spirostanylglykosidal-krystaller

Info

Publication number
NO970910D0
NO970910D0 NO970910A NO970910A NO970910D0 NO 970910 D0 NO970910 D0 NO 970910D0 NO 970910 A NO970910 A NO 970910A NO 970910 A NO970910 A NO 970910A NO 970910 D0 NO970910 D0 NO 970910D0
Authority
NO
Norway
Prior art keywords
spirostanylglykosidal
crystals
spirostanylglykosidal crystals
Prior art date
Application number
NO970910A
Other languages
English (en)
Other versions
NO970910L (no
Inventor
Douglas J Allen
Sr Richard A Buzon
Michael P Deninno
Jr Harry A Watson
Jonathan B Zung
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO970910D0 publication Critical patent/NO970910D0/no
Publication of NO970910L publication Critical patent/NO970910L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO970910A 1994-08-30 1997-02-27 Spirostanylglykosidal-krystaller NO970910L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29810694A 1994-08-30 1994-08-30
PCT/IB1995/000317 WO1996006854A1 (en) 1994-08-30 1995-05-04 Spirostanyl glycosidal crystals

Publications (2)

Publication Number Publication Date
NO970910D0 true NO970910D0 (no) 1997-02-27
NO970910L NO970910L (no) 1997-02-27

Family

ID=23149057

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970910A NO970910L (no) 1994-08-30 1997-02-27 Spirostanylglykosidal-krystaller

Country Status (20)

Country Link
US (1) US5804562A (no)
EP (1) EP0778846A1 (no)
JP (1) JPH09510735A (no)
KR (1) KR970705574A (no)
AU (1) AU2265395A (no)
BR (1) BR9503827A (no)
CA (1) CA2198097A1 (no)
CO (1) CO4480032A1 (no)
FI (1) FI970828A0 (no)
HR (1) HRP950459A2 (no)
IL (1) IL115062A0 (no)
MA (1) MA23651A1 (no)
MX (1) MX9701525A (no)
NO (1) NO970910L (no)
OA (1) OA10402A (no)
PE (1) PE47696A1 (no)
PL (1) PL318937A1 (no)
SI (1) SI9520092A (no)
TR (1) TR199501065A2 (no)
WO (1) WO1996006854A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1066033B1 (en) * 1998-03-26 2005-12-28 Phytopharm Plc Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
KR101130212B1 (ko) * 2002-03-27 2012-04-13 파이토팜 피엘씨 사포게닌 및 그 유도체의 치료 방법 및 사용법
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629295A (en) * 1992-06-26 1997-05-13 Pfizer Inc. Steroidal glycosides for treating hypercholesterolemia
AU7948494A (en) * 1993-12-28 1995-07-17 Pfizer Inc. Steroidal glycosides

Also Published As

Publication number Publication date
JPH09510735A (ja) 1997-10-28
KR970705574A (ko) 1997-10-09
EP0778846A1 (en) 1997-06-18
CA2198097A1 (en) 1996-03-07
PE47696A1 (es) 1996-11-12
FI970828A7 (fi) 1997-02-27
MX9701525A (es) 1997-05-31
AU2265395A (en) 1996-03-22
BR9503827A (pt) 1996-09-10
NO970910L (no) 1997-02-27
US5804562A (en) 1998-09-08
SI9520092A (en) 1997-12-31
PL318937A1 (en) 1997-07-21
OA10402A (en) 2001-12-05
MA23651A1 (fr) 1996-04-01
TR199501065A2 (tr) 1996-06-21
WO1996006854A1 (en) 1996-03-07
IL115062A0 (en) 1995-12-08
CO4480032A1 (es) 1997-07-09
HRP950459A2 (en) 1997-08-31
FI970828L (fi) 1997-02-27
FI970828A0 (fi) 1997-02-27

Similar Documents

Publication Publication Date Title
FI954008L (fi) Substituoituja bifenyyli-isoksatsolisulfoniamideja
FI951908L (fi) Substituoituja pyridyylipyratsoleja
DE69521898D1 (de) Verbesserter polarisator
FI955927A0 (fi) Substituoidut 1H-imidatsolit
ATA166795A (de) Bis-resorcinyltriazine
ATA163695A (de) 2-hydroxyphenyltriazine
DE69534718D1 (de) Substituierte 9-alkyladenine
FI944940A0 (fi) Tvaofasigt separeringsfoerfarande
DE69531247D1 (de) Orientierte kristallanordnung
ATA108995A (de) Differenzdruckakkumulator
NO970910D0 (no) Spirostanylglykosidal-krystaller
BR9509559A (pt) Azolilulsolfonilfeniluracilas substituídas
DE69508469D1 (de) Oxyde-Granat-Einkristall
NO971686L (no) HER4-humanreseptortyrosinkinase
DE59510274D1 (de) Substituierte biphenyloxazoline
BR7400683U (pt) Odontoportátil
KR960002814U (ko) 문제지
KR960019939U (ko) 제기
FI1497U1 (fi) Upphaengningsankarenhet
FI1324U1 (fi) Maetnings- och regleringsanordning foer luftstroemmar
ATE197372T1 (de) Vorteig
BR7400242U (pt) Tele-comando
BR7400030U (pt) Numeralfa
BR7400170U (pt) Mouráo
BR7400635U (pt) Entopstop